Distributed by

ROCHE HONG KONG LTD

Featured products of Roche

ALECENSA

ALECENSA cap 150 mg

alectinib

Packing/Price

224's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01ED03 - alectinib : Belongs to the class of anaplastic lymphoma kinase (ALK) inhibitors. Used in the treatment of cancer.

Avastin Roche

Avastin Roche infusion 100 mg/4 mL

bevacizumab

Packing/Price

(single-use) 1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FG01 - bevacizumab : Belongs to the class of VEGF/VEGFR (Vascular Endothelial Growth Factor) inhibitors. Used in the treatment of cancer.

Polivy

Polivy powd for concentrate for soln for infusion 140 mg

polatuzumab vedotin

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FX14 - polatuzumab vedotin : Belongs to the class of other monoclonal antibodies and antibody drug conjugates. Used in the treatment of cancer.

Polivy powd for concentrate for soln for infusion 30 mg

polatuzumab vedotin

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FX14 - polatuzumab vedotin : Belongs to the class of other monoclonal antibodies and antibody drug conjugates. Used in the treatment of cancer.

Tecentriq

Tecentriq conc for soln for infusion 1,200 mg/20 mL

atezolizumab

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy, Cancer Immunotherapy

ATC Classification

L01FF05 - atezolizumab : Belongs to the class of PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors. Used in the treatment of cancer.

Tecentriq conc for soln for infusion 840 mg/14 mL

atezolizumab

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy, Cancer Immunotherapy

ATC Classification

L01FF05 - atezolizumab : Belongs to the class of PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors. Used in the treatment of cancer.

Vabysmo

Vabysmo soln for intravitreal inj 6 mg/0.05 mL

faricimab

Packing/Price

1's

MIMS Class

Other Eye Preparations

ATC Classification

S01LA09 - faricimab : Belongs to the class antineovasculatisation agents. Used in the management of neovascular macular degeneration.

Xofluza

Xofluza FC tab 20 mg

baloxavir marboxil

Packing/Price

4's2's

MIMS Class

Antivirals

ATC Classification

J05AX25 - baloxavir marboxil : Belongs to the class of other antivirals. Used as a direct acting antiviral in the systemic treatment of viral infections.

Xofluza FC tab 40 mg

baloxavir marboxil

Packing/Price

1's2's

MIMS Class

Antivirals

ATC Classification

J05AX25 - baloxavir marboxil : Belongs to the class of other antivirals. Used as a direct acting antiviral in the systemic treatment of viral infections.

Distributed by Agencia Lei Va Hong

ALECENSA

ALECENSA cap 150 mg

alectinib

Packing/Price

224's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01ED03 - alectinib : Belongs to the class of anaplastic lymphoma kinase (ALK) inhibitors. Used in the treatment of cancer.

Avastin Roche

Avastin Roche infusion 100 mg/4 mL

bevacizumab

Packing/Price

(single-use) 1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FG01 - bevacizumab : Belongs to the class of VEGF/VEGFR (Vascular Endothelial Growth Factor) inhibitors. Used in the treatment of cancer.

Tecentriq

Tecentriq conc for soln for infusion 1,200 mg/20 mL

atezolizumab

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy, Cancer Immunotherapy

ATC Classification

L01FF05 - atezolizumab : Belongs to the class of PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors. Used in the treatment of cancer.

Tecentriq conc for soln for infusion 840 mg/14 mL

atezolizumab

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy, Cancer Immunotherapy

ATC Classification

L01FF05 - atezolizumab : Belongs to the class of PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors. Used in the treatment of cancer.

Distributed by DKSH

ALECENSA

ALECENSA cap 150 mg

alectinib

Packing/Price

224's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01ED03 - alectinib : Belongs to the class of anaplastic lymphoma kinase (ALK) inhibitors. Used in the treatment of cancer.

Avastin Roche

Avastin Roche infusion 100 mg/4 mL

bevacizumab

Packing/Price

(single-use) 1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FG01 - bevacizumab : Belongs to the class of VEGF/VEGFR (Vascular Endothelial Growth Factor) inhibitors. Used in the treatment of cancer.

Polivy

Polivy powd for concentrate for soln for infusion 140 mg

polatuzumab vedotin

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FX14 - polatuzumab vedotin : Belongs to the class of other monoclonal antibodies and antibody drug conjugates. Used in the treatment of cancer.

Polivy powd for concentrate for soln for infusion 30 mg

polatuzumab vedotin

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FX14 - polatuzumab vedotin : Belongs to the class of other monoclonal antibodies and antibody drug conjugates. Used in the treatment of cancer.

Tecentriq

Tecentriq conc for soln for infusion 1,200 mg/20 mL

atezolizumab

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy, Cancer Immunotherapy

ATC Classification

L01FF05 - atezolizumab : Belongs to the class of PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors. Used in the treatment of cancer.

Tecentriq conc for soln for infusion 840 mg/14 mL

atezolizumab

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy, Cancer Immunotherapy

ATC Classification

L01FF05 - atezolizumab : Belongs to the class of PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors. Used in the treatment of cancer.

Vabysmo

Vabysmo soln for intravitreal inj 6 mg/0.05 mL

faricimab

Packing/Price

1's

MIMS Class

Other Eye Preparations

ATC Classification

S01LA09 - faricimab : Belongs to the class antineovasculatisation agents. Used in the management of neovascular macular degeneration.

Xofluza

Xofluza FC tab 20 mg

baloxavir marboxil

Packing/Price

4's2's

MIMS Class

Antivirals

ATC Classification

J05AX25 - baloxavir marboxil : Belongs to the class of other antivirals. Used as a direct acting antiviral in the systemic treatment of viral infections.

Xofluza FC tab 40 mg

baloxavir marboxil

Packing/Price

1's2's

MIMS Class

Antivirals

ATC Classification

J05AX25 - baloxavir marboxil : Belongs to the class of other antivirals. Used as a direct acting antiviral in the systemic treatment of viral infections.